Max Chat
Company Analysis Perfect Medical Health Management Limited
1. Summary
Advantages
- Price (1.65 HK$) is less than fair price (2.24 HK$)
- Dividends (9.72%) are higher than the sector average (5.4%).
- The company's current efficiency (ROE=56.91%) is higher than the sector average (ROE=-12.05%)
Disadvantages
- The stock's return over the last year (-32.1%) is lower than the sector average (11.45%).
- Current debt level 21.99% has increased over 5 years from 0%.
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Perfect Medical Health Management Limited | Consumer Cyclical | Index | |
|---|---|---|---|
| 7 days | -2.9% | -0.5% | 1.3% |
| 90 days | -24% | 44.9% | 13% |
| 1 year | -32.1% | 11.4% | 34.3% |
1830 vs Sector: Perfect Medical Health Management Limited has significantly underperformed the "Consumer Cyclical" sector by -43.54% over the past year.
1830 vs Market: Perfect Medical Health Management Limited has significantly underperformed the market by -66.44% over the past year.
Stable price: 1830 is not significantly more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 1830 with weekly volatility of -0.6173% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (1.65 HK$) is lower than the fair price (2.24 HK$).
Price significantly below the fair price: The current price (1.65 HK$) is 35.8% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (12.73) is lower than that of the sector as a whole (129.64).
P/E vs Market: The company's P/E (12.73) is lower than that of the market as a whole (43.79).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (8.09) is higher than that of the sector as a whole (3.57).
P/BV vs Market: The company's P/BV (8.09) is higher than that of the market as a whole (1.59).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.89) is higher than that of the sector as a whole (2.13).
P/S vs Market: The company's P/S indicator (2.89) is higher than that of the market as a whole (2.5).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (6.43) is lower than that of the sector as a whole (23.98).
EV/Ebitda vs Market: The company's EV/Ebitda (6.43) is lower than that of the market as a whole (9.93).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -2.46% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-2.46%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-8.95%).
5.4. ROE
ROE vs Sector: The company's ROE (56.91%) is higher than that of the sector as a whole (-12.05%).
ROE vs Market: The company's ROE (56.91%) is higher than that of the market as a whole (2.89%).
5.5. ROA
ROA vs Sector: The company's ROA (25.08%) is higher than that of the sector as a whole (4.7%).
ROA vs Market: The company's ROA (25.08%) is higher than that of the market as a whole (3.12%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (20.88%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (20.88%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 9.72% is higher than the average for the sector '5.4%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 9.72% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 9.72% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (124.11%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
